JPWO2022168971A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022168971A5 JPWO2022168971A5 JP2022579640A JP2022579640A JPWO2022168971A5 JP WO2022168971 A5 JPWO2022168971 A5 JP WO2022168971A5 JP 2022579640 A JP2022579640 A JP 2022579640A JP 2022579640 A JP2022579640 A JP 2022579640A JP WO2022168971 A5 JPWO2022168971 A5 JP WO2022168971A5
- Authority
- JP
- Japan
- Prior art keywords
- implantation rate
- structural formula
- compound represented
- improving
- mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002513 implantation Methods 0.000 claims 5
- 241000124008 Mammalia Species 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021018210 | 2021-02-08 | ||
| PCT/JP2022/004638 WO2022168971A1 (ja) | 2021-02-08 | 2022-02-07 | 哺乳動物における着床率の調節方法、哺乳動物における着床率の向上剤、及び医薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022168971A1 JPWO2022168971A1 (https=) | 2022-08-11 |
| JPWO2022168971A5 true JPWO2022168971A5 (https=) | 2025-01-24 |
Family
ID=82741582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022579640A Pending JPWO2022168971A1 (https=) | 2021-02-08 | 2022-02-07 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2022168971A1 (https=) |
| WO (1) | WO2022168971A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8702711D0 (sv) * | 1987-06-30 | 1987-06-30 | Biocarb Ab | Birth control and diagnostic methods |
| WO2011123041A1 (en) * | 2010-04-01 | 2011-10-06 | Karolinska Institutet Innovation Ab | Fertilization prediction and promotion |
| EP3714896A4 (en) * | 2017-11-21 | 2021-08-04 | Miwa, Naofumi | MEANS FOR INHIBITING METASTASISATION OF HUMAN CANCER CELLS AND MEANS FOR DETERMINING HUMAN CANCER CELLS |
-
2022
- 2022-02-07 WO PCT/JP2022/004638 patent/WO2022168971A1/ja not_active Ceased
- 2022-02-07 JP JP2022579640A patent/JPWO2022168971A1/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024100936A5 (https=) | ||
| JP2008538183A5 (https=) | ||
| JPH0829097B2 (ja) | 線維芽細胞発育因子 | |
| JP2020511115A5 (https=) | ||
| JP2011004753A5 (https=) | ||
| JP2024099833A5 (https=) | ||
| DE3625257A1 (de) | Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika | |
| SK704783A3 (en) | Dna sequences, recombinant molecules of dna and a method of producing polypeptides similar to sow growth hormone | |
| CN1215397A (zh) | 具有免疫调解剂作用的酰化n－羟甲基酞胺哌啶酮－前药 | |
| JP2021514003A5 (https=) | ||
| JP2024102242A5 (https=) | ||
| JP2014508164A5 (https=) | ||
| JPWO2019101648A5 (https=) | ||
| EP3991743A1 (en) | Immune inducer and pharmaceutical composition for preventing or treating aging-related diseases | |
| JPWO2022168971A5 (https=) | ||
| JP2022528252A5 (https=) | ||
| Klein | Of HLA, tryps, and selection: an essay on coevolution of MHC and parasites | |
| JPWO2022018186A5 (https=) | ||
| JP2008517998A5 (https=) | ||
| CN111655282A (zh) | 一种对抗动物增生性肠病的重组疫苗 | |
| CN102166348B (zh) | 抑制素重组融合蛋白在制备促进母猪发情和配种药物方面的应用 | |
| JPWO2022239765A5 (https=) | ||
| JP5174022B2 (ja) | 膵臓β細胞増加促進剤及び膵臓β細胞増加促進組成物 | |
| JPWO2023058337A5 (https=) | ||
| EP1631586B1 (fr) | Analogues peptidiques comprenant au moins un residu aza-beta 3 aminoacyle, et leurs utilisations, notamment en therapie |